What is gene therapy and how is it being in treating ADA deficiency patients
Answers
Answered by
0
The high cost of ERT and the required life-long injections limits its access and may create severe financial burdens on patients and their families. Because of the limitations of these conventional therapies, gene correction of autologous HSC has been explored as a potentially curative treatment for ADA-deficient SCID.
Similar questions